Skip to main content
    U

    Ultralife Corporation (ULBI)

    Official site

    INDUSTRIALS • ELECTRICAL EQUIPMENT & PARTS • NASDAQ

    $15.67
    -0.01 (-0.06%)

    Market Cap: $261.30M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Ultralife Corporation (ULBI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Ultralife (ULBI) has a market cap of $261.30M and an enterprise value of $303.19M. It earned -$3.02M on revenue of $192.14M over the last 12 months.

    Total Valuation

    Enterprise value is 16.03% above the market cap, as debt exceeds cash.

    Market Cap$261.30M
    Enterprise Value$303.19M
    Latest price (Nov 17, 2026)$15.67

    Key Dates

    The next earnings report is expected on Mar 8, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 8, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.03% in the quarter ended Sep 30, 2026 and grew 0.12% a year over 2 years.

    Shares Outstanding16.66M
    Shares Change (YoY)+0.11%
    Shares Change (QoQ)+0.03%
    Share Count Growth (2Y CAGR)+0.12%

    Valuation Ratios

    Sales and book value multiples are 1.4x and 1.9x. Its year-end P/S ranged from 0.5x to 1.2x from 2016 to 2025.

    P/S Ratio1.4x
    Forward P/S1.2x
    P/B Ratio1.9x
    P/TBV Ratio3.3x
    P/OCF Ratio130.5x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 75.9x EBITDA.

    EV / Sales1.6x
    EV / EBITDA75.9x

    Price Statistics

    The stock is up 181.83% over 52 weeks and trades 75.28% above its 50-day average.

    Beta (1Y)1.04
    52-Week Change+181.83%
    1-Month Change+158.58%
    3-Month Change+123.86%
    6-Month Change+161.17%
    5-Year Change+149.52%
    10-Year Change+280.98%
    Total Return (1Y)+181.83%
    Total Return (3Y CAGR)+28.52%
    Total Return (5Y CAGR)+21.72%
    Return vs SPY (1Y)+198.74%
    Max Drawdown (1Y)-35.09%
    Max Drawdown (3Y)-68.83%
    Sharpe Ratio (1Y)1.10
    Correlation with SPY (1Y)0.14
    50-Day Average$8.94
    200-Day Average$7.02
    52-Week Range$4.90 to $15.83
    RSI (14 Days)90.6
    Average Volume (20 Days)315.86K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.97x current liabilities, and total debt is 0.38x shareholder equity.

    Current Ratio2.97x
    Quick Ratio1.38x
    Debt / Equity0.38x
    Debt / EBITDA12.65x
    Interest Coverage5.28x

    Returns and Efficiency

    Return on invested capital is -0.55% over the last 12 months, against a 5-year average of 1.71%.

    Return on Equity (ROE)-2.25%
    Return on Assets (ROA)-1.35%
    Return on Invested Capital (ROIC)-0.55%
    Return on Capital Employed (ROCE)-0.85%
    ROE (5Y Average)1.12%
    ROA (5Y Average)0.79%
    ROIC (5Y Average)1.71%
    Asset Turnover0.86x
    Inventory Turnover2.36x
    Receivables Turnover5.45x
    Cash Conversion Cycle168 days

    Scores

    ULBI has an Altman Z-Score of 2.77, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score2.77
    Altman Z ZoneGrey
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $192.14M over the last 12 months is up 3.01% from the 12 months before.

    Revenue$192.14M
    Revenue Growth (YoY)+3.01%
    Gross Profit$49.33M
    Operating Income-$4.20M
    Pretax Income-$5.14M
    Net Income-$3.02M
    EBITDA$3.99M
    EBIT-$1.57M
    Reported EPS (TTM)-$0.15

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 59.95% of the $224.40M in total assets.

    Cash and Equivalents$8.63M
    Total Debt$50.52M
    Net Debt$41.89M
    Net Debt Per Share$2.51
    Working Capital$77.33M
    Shareholder Equity$134.53M
    Book Value Per Share$8.07
    Tangible Book Value$79.00M
    Tangible Book Per Share$4.74
    Total Assets$224.40M
    Total Liabilities$89.77M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $2.70M of capital spending, operating cash flow left -$694.00K of free cash flow.

    Operating Cash Flow$2.00M
    Capital Expenditures$2.70M
    Free Cash Flow-$694.00K
    FCF Per Share-$0.04
    Depreciation and Amortization$5.57M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -2.18%, against a 5-year average of 1.82%.

    Gross Margin25.67%
    Operating Margin-2.18%
    Pretax Margin-2.67%
    Net Margin-1.57%
    EBITDA Margin2.08%
    EBIT Margin-0.82%
    FCF Margin-0.36%
    Gross Margin (5Y Average)24.38%
    Operating Margin (5Y Average)1.82%
    Net Margin (5Y Average)1.00%

    Growth

    Revenue grew 13.18% a year over 3 years.

    Revenue Growth (3Y CAGR)+13.18%
    Revenue Growth (5Y CAGR)+12.16%
    FCF Growth (5Y CAGR)-17.49%
    Book Value Per Share Growth (2Y CAGR)+1.31%
    Tangible Book Per Share Growth (2Y CAGR)+0.18%

    Revenue and profit by year

    Dividends and Yields

    ULBI does not pay a dividend. Its free cash flow yield is -0.27%.

    FCF Yield-0.27%
    Shareholder Yield0.00%

    Peer Position

    Against 11 similar companies, ULBI has the 7th highest P/S and the 5th highest ROIC.

    P/S Ratio1.4x vs 2.0x median
    ROIC-0.55% vs -11.89% median
    Revenue Growth (Trailing 4 Quarters, YoY)+3.01% vs +13.04% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 17.65% a year over the next fiscal year.

    Revenue Growth Forecast (1Y CAGR)+17.65%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ULBI

    What is ULBI's market cap?

    Ultralife has a market cap of $261.30M. Its enterprise value, which adds debt and subtracts cash, is $303.19M.

    How many shares of ULBI are outstanding?

    Ultralife has 16.66M shares outstanding. The count is up 0.11% from a year earlier.

    Does ULBI pay a dividend?

    No. Ultralife does not pay a dividend.

    How much debt does ULBI have?

    Ultralife has $50.52M of total debt and $8.63M of cash and equivalents, a net debt position of $41.89M.